Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaLogic

Full company profile

uuid0009ohk

Namestring
PharmaLogic
Legal namestring
PharmaLogic Development, Inc.
Websiteurl
pharmalogic.com
Company typeenum
Private
Founded yearint
1984
Descriptiontext

PharmaLogic Development, Inc. is a privately held pharmaceutical and medical device consultancy headquartered in San Rafael, California, founded approximately 40 years ago by Gary D. Novack, Ph.D. The firm provides strategic direction and tactical execution for development of novel pharmaceuticals, biologics, and medical devices, with particular expertise in local therapy areas of ophthalmology and dermatology, and additional experience in neurology. Service offerings span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), FDA client representation, scientific communications and medical writing, safety assessment, and licensing representation. The firm has contributed to over 40 approved products, over 120 IND and IDE submissions, and over 360 published papers, with Dr. Novack individually authoring over 400 publications.

The firm operates as a professional services consultancy with a sales-led go-to-market model built primarily on professional networks, academic conferences (ARVO, AAO, AOPT, American Glaucoma Society), and direct consulting engagements. Pricing is quote-based and negotiated per project, with no public pricing disclosure. The client base spans over 600 pharmaceutical and medical device companies across four continents, with named clients including Zhaoke Ophthalmology Limited and Glaukos Corporation. Marketing and brand building is conducted almost entirely through Dr. Novack's personal publication record, speaking engagements, editorial board positions, and media appearances including The New York Times and UC Davis Health. Distribution is relationship-based direct engagement rather than product distribution.

PharmaLogic is a founder-led, lean organization (11-50 employees) with no identified parent company, no institutional investment, no funding rounds, and no M&A activity. The core team consists of Dr. Novack as President and Dona Ann Novack as Director of Information Services, supported by a team of senior experts. The business model is fundamentally tied to Dr. Novack's personal expertise, academic affiliations (UC Davis Professor and Vice Chair of Collaborative Research), and industry credentials (Fellow of ARVO, AOPT, American College of Clinical Pharmacology). This concentrated key-person dependency is both the firm's primary asset and its most significant structural limitation.

Short descriptiontext

PharmaLogic Development is a privately held San Rafael, California-based consultancy providing strategic and tactical drug development consulting for pharmaceutical and medical device companies, with particular expertise in ophthalmology, dermatology, and neurology. The firm serves 600+ clients globally across the regulatory, clinical, and medical writing spectrum.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting, drug development services, regulatory affairs consulting, clinical trial design, medical device consulting
Industry2 codes
PRIMARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Pharmaceutical Consulting Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

PharmaLogic provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services include drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), scientific publications, and business development consulting. The firm works with pharmaceutical and medical device companies from candidate selection through NDA and marketing support.

pharmalogic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PharmaLogic Development, Inc. is a consultancy providing strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), preclinical data review, candidate selection, licensing representation, scientific/medical writing, and FDA client representation, with particular expertise in local therapy (ophthalmology and dermatology).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 40 approved products developed with client contributions
+3 more records
Product overview1 text field

PharmaLogic Development, Inc. is a consultancy that provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. The company does not offer a software product or platform, but rather provides consulting services including regulatory affairs (NDA/Preclinical and clinical reports, FDA client representation), clinical trials support (Trial Outlines, Protocol Design, Biostatistical Evaluation, Medical Final Reports), and product research and development (Preclinical Data Review, Candidate Selection, Licensing Representation, Business Plans, IND Preparation). Their primary therapeutic areas are ophthalmology, dermatology, and neurology. The firm has contributed to over 40 approved products in these therapeutic areas and has served over 600 clients on four continents.

Product and service6 records
1Drug Development Planning Consulting
CategoryRegulatory Affairs Consulting
Description

Strategic consulting on drug development planning from candidate selection through regulatory approval, helping pharmaceutical and medical device companies navigate the complex, expensive, and risky medical product development journey.

2FDA Regulatory Submission Services
CategoryRegulatory Affairs Consulting
Description

Preparation and submission of regulatory filings to the FDA, including Investigational New Drug (IND) applications, Investigational Device Exemptions (IDEs), New Drug Applications (NDAs), and Premarket Approvals (PMAs), along with FDA client representation.

3Clinical Trial Design Services
CategoryClinical Development Consulting
Description

Consulting on clinical trial outlines, protocol design, biostatistical evaluation, and medical final reports for pharmaceutical and medical device development programs.

4Medical Writing and Scientific Publications
CategoryMedical Writing Services
Description

Medical writing and scientific publication services for pharmaceutical and medical device clients, including preparation of manuscripts, regulatory documents, and clinical reports for publication in peer-reviewed journals.

5Preclinical Data Review and Candidate Selection
CategoryDrug Development Consulting
Description

Consulting on preclinical data review and candidate selection to support pharmaceutical and medical device development decision-making, including formulation (pharmaceutics), safety assessment, and clinical planning integration.

6Licensing Representation and Business Plans
CategoryBusiness Development Consulting
Description

Product licensing representation and business plan development for pharmaceutical and medical device companies seeking to commercialize or partner assets under development.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

PharmaLogic Development, Inc. was contracted to provide service to Zhaoke Ophthalmology Limited in their ophthalmic product development. This represents a client-service relationship where PharmaLogic provides consulting expertise.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ora is a clinical research organization specializing in ophthalmology and ENT drug and device development. It is the most direct peer to PharmaLogic because both firms concentrate regulatory, clinical, and product-development expertise in the ophthalmology therapeutic area for which PharmaLogic is best known.

TypeBroad incumbent
Description

Worldwide Clinical Trials is a mid-sized global CRO providing clinical trial management and drug development services across multiple therapeutic areas. It is a broad incumbent peer because it competes for outsourced development engagements that include the kind of regulatory strategy work PharmaLogic provides to sponsors.

3Camargo Pharmaceutical Services
TypeDirect peer
Description

Camargo specializes in regulatory affairs consulting for the pharmaceutical industry, with particular strength in 505(b)(2) development and complex generic programs. It is a direct peer because it directly competes for the same regulatory strategy and FDA submission engagements that are core to PharmaLogic's offering.

TypeBroad incumbent
Description

Charles River Laboratories provides early-stage drug discovery, preclinical, and clinical development services to pharma and biotech sponsors. It is a broad incumbent peer because it covers portions of the development value chain — particularly preclinical and early clinical — that touch PharmaLogic's consulting scope.

TypeDirect peer
Description

ProPharma Group is a pharmaceutical consulting firm providing regulatory affairs, clinical research, and compliance support across drug development lifecycle. It is a direct peer because it competes with PharmaLogic for the same pharma sponsor consulting engagements and offers overlapping services like IND/NDA preparation.

TypeBroad incumbent
Description

ICON is a global CRO providing a broad range of drug development and consulting services to pharma and biotech sponsors. It is a broad incumbent peer because it competes for outsourced drug development engagements and offers services adjacent to PharmaLogic's regulatory and clinical strategy offerings.

TypeBroad incumbent
Description

Medpace is a mid-sized global CRO offering full-service clinical development across therapeutic areas. It is a broad incumbent peer because, while not ophthalmology-specialized, it provides drug development services that overlap with PharmaLogic's value proposition for sponsors seeking consolidated development support.

TypeDirect peer
Description

Advanced Clinical is a CRO and clinical development services firm working with biotech and mid-sized pharma sponsors. It is a direct peer because it serves a similar client profile of small and mid-sized pharma/biotech sponsors seeking outsourced development support, including clinical and regulatory services.

TypeDirect peer
Description

Nuventra is a clinical pharmacology and drug development consulting firm supporting small and mid-sized pharma companies. It is a direct peer because it operates in the same small-consultant niche of clinical pharmacology and regulatory strategy that PharmaLogic serves.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and clinical development services provider with a comprehensive portfolio spanning R&D, regulatory, and commercial services. It is a broad incumbent peer because it competes for the same outsourced drug development work and increasingly offers specialized therapeutic-area advisory services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaLogic

Pharmaceutical Consulting Servicespharmalogic.com

PharmaLogic Development is a privately held San Rafael, California-based consultancy providing strategic and tactical drug development consulting for pharmaceutical and medical device companies, with particular expertise in ophthalmology, dermatology, and neurology. The firm serves 600+ clients globally across the regulatory, clinical, and medical writing spectrum.

What PharmaLogic does

PharmaLogic Development, Inc. is a privately held pharmaceutical and medical device consultancy headquartered in San Rafael, California, founded approximately 40 years ago by Gary D. Novack, Ph.D. The firm provides strategic direction and tactical execution for development of novel pharmaceuticals, biologics, and medical devices, with particular expertise in local therapy areas of ophthalmology and dermatology, and additional experience in neurology. Service offerings span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), FDA client representation, scientific communications and medical writing, safety assessment, and licensing representation. The firm has contributed to over 40 approved products, over 120 IND and IDE submissions, and over 360 published papers, with Dr. Novack individually authoring over 400 publications.

The firm operates as a professional services consultancy with a sales-led go-to-market model built primarily on professional networks, academic conferences (ARVO, AAO, AOPT, American Glaucoma Society), and direct consulting engagements. Pricing is quote-based and negotiated per project, with no public pricing disclosure. The client base spans over 600 pharmaceutical and medical device companies across four continents, with named clients including Zhaoke Ophthalmology Limited and Glaukos Corporation. Marketing and brand building is conducted almost entirely through Dr. Novack's personal publication record, speaking engagements, editorial board positions, and media appearances including The New York Times and UC Davis Health. Distribution is relationship-based direct engagement rather than product distribution.

PharmaLogic is a founder-led, lean organization (11-50 employees) with no identified parent company, no institutional investment, no funding rounds, and no M&A activity. The core team consists of Dr. Novack as President and Dona Ann Novack as Director of Information Services, supported by a team of senior experts. The business model is fundamentally tied to Dr. Novack's personal expertise, academic affiliations (UC Davis Professor and Vice Chair of Collaborative Research), and industry credentials (Fellow of ARVO, AOPT, American College of Clinical Pharmacology). This concentrated key-person dependency is both the firm's primary asset and its most significant structural limitation.

PharmaLogic firmographics

Firmographics
Name
PharmaLogic
Legal name
PharmaLogic Development, Inc.
Website
https://pharmalogic.com
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
1–10 employees
Short description
PharmaLogic Development is a privately held San Rafael, California-based consultancy providing strategic and tactical drug development consulting for pharmaceutical and medical device companies, with particular expertise in ophthalmology, dermatology, and neurology. The firm serves 600+ clients globally across the regulatory, clinical, and medical writing spectrum.
Ownership category
akta.pro rank

PharmaLogic industry classification

Industry
Product category
Pharmaceutical Consulting Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAAAL
Ophthalmology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical consulting
  • Drug development services
  • Regulatory affairs consulting
  • Clinical trial design
  • Medical device consulting

Where PharmaLogic is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PharmaLogic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Consulting Services: PharmaLogic provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services include drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), scientific publications, and business development consulting. The firm works with pharmaceutical and medical device companies from candidate selection through NDA and marketing support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

PharmaLogic product offering

Product offering

Core offering

PharmaLogic Development, Inc. is a consultancy providing strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), preclinical data review, candidate selection, licensing representation, scientific/medical writing, and FDA client representation, with particular expertise in local therapy (ophthalmology and dermatology).

Product overview

PharmaLogic Development, Inc. is a consultancy that provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. The company does not offer a software product or platform, but rather provides consulting services including regulatory affairs (NDA/Preclinical and clinical reports, FDA client representation), clinical trials support (Trial Outlines, Protocol Design, Biostatistical Evaluation, Medical Final Reports), and product research and development (Preclinical Data Review, Candidate Selection, Licensing Representation, Business Plans, IND Preparation). Their primary therapeutic areas are ophthalmology, dermatology, and neurology. The firm has contributed to over 40 approved products in these therapeutic areas and has served over 600 clients on four continents.

Differentiator

Problem solved

Functional benefit

Products and services

  • Drug Development Planning Consulting Strategic consulting on drug development planning from candidate selection through regulatory approval, helping pharmaceutical and medical device companies navigate the complex, expensive, and risky medical product development journey.
  • FDA Regulatory Submission Services Preparation and submission of regulatory filings to the FDA, including Investigational New Drug (IND) applications, Investigational Device Exemptions (IDEs), New Drug Applications (NDAs), and Premarket Approvals (PMAs), along with FDA client representation.
  • Clinical Trial Design Services Consulting on clinical trial outlines, protocol design, biostatistical evaluation, and medical final reports for pharmaceutical and medical device development programs.
  • Medical Writing and Scientific Publications Medical writing and scientific publication services for pharmaceutical and medical device clients, including preparation of manuscripts, regulatory documents, and clinical reports for publication in peer-reviewed journals.
  • Preclinical Data Review and Candidate Selection Consulting on preclinical data review and candidate selection to support pharmaceutical and medical device development decision-making, including formulation (pharmaceutics), safety assessment, and clinical planning integration.
  • Licensing Representation and Business Plans Product licensing representation and business plan development for pharmaceutical and medical device companies seeking to commercialize or partner assets under development.

Quantifiable outcome

  • Over 40 approved products developed with client contributions
  • +3 more outcomes

Companies that use PharmaLogic

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

PharmaLogic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

PharmaLogic partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Zhaoke Ophthalmology LimitedminorOthersPharmaLogic Development, Inc. was contracted to provide service to Zhaoke Ophthalmology Limited in their ophthalmic product development. This represents a client-service relationship where PharmaLogic provides consulting expertise.

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

PharmaLogic competitors and assessment

Company assessment

Direct peers

  • Ora, Inc. Ora is a clinical research organization specializing in ophthalmology and ENT drug and device development. It is the most direct peer to PharmaLogic because both firms concentrate regulatory, clinical, and product-development expertise in the ophthalmology therapeutic area for which PharmaLogic is best known.
  • Camargo Pharmaceutical Services: Camargo specializes in regulatory affairs consulting for the pharmaceutical industry, with particular strength in 505(b)(2) development and complex generic programs. It is a direct peer because it directly competes for the same regulatory strategy and FDA submission engagements that are core to PharmaLogic's offering.
  • ProPharma Group: ProPharma Group is a pharmaceutical consulting firm providing regulatory affairs, clinical research, and compliance support across drug development lifecycle. It is a direct peer because it competes with PharmaLogic for the same pharma sponsor consulting engagements and offers overlapping services like IND/NDA preparation.
  • Advanced Clinical: Advanced Clinical is a CRO and clinical development services firm working with biotech and mid-sized pharma sponsors. It is a direct peer because it serves a similar client profile of small and mid-sized pharma/biotech sponsors seeking outsourced development support, including clinical and regulatory services.
  • Nuventra Pharma Sciences: Nuventra is a clinical pharmacology and drug development consulting firm supporting small and mid-sized pharma companies. It is a direct peer because it operates in the same small-consultant niche of clinical pharmacology and regulatory strategy that PharmaLogic serves.

Broad incumbents

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO providing clinical trial management and drug development services across multiple therapeutic areas. It is a broad incumbent peer because it competes for outsourced development engagements that include the kind of regulatory strategy work PharmaLogic provides to sponsors.
  • Charles River Laboratories: Charles River Laboratories provides early-stage drug discovery, preclinical, and clinical development services to pharma and biotech sponsors. It is a broad incumbent peer because it covers portions of the development value chain — particularly preclinical and early clinical — that touch PharmaLogic's consulting scope.
  • ICON plc: ICON is a global CRO providing a broad range of drug development and consulting services to pharma and biotech sponsors. It is a broad incumbent peer because it competes for outsourced drug development engagements and offers services adjacent to PharmaLogic's regulatory and clinical strategy offerings.
  • Medpace: Medpace is a mid-sized global CRO offering full-service clinical development across therapeutic areas. It is a broad incumbent peer because, while not ophthalmology-specialized, it provides drug development services that overlap with PharmaLogic's value proposition for sponsors seeking consolidated development support.
  • IQVIA: IQVIA is the largest global CRO and clinical development services provider with a comprehensive portfolio spanning R&D, regulatory, and commercial services. It is a broad incumbent peer because it competes for the same outsourced drug development work and increasingly offers specialized therapeutic-area advisory services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

PharmaLogic social profiles

Digital presence

PharmaLogic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaLogic leadership team

Management profile

Number of profiles

Profiles2 records

PharmaLogic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaLogic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaLogic

What does PharmaLogic do?

PharmaLogic Development, Inc. is a consultancy providing strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), preclinical data review, candidate selection, licensing representation, scientific/medical writing, and FDA client representation, with particular expertise in local therapy (ophthalmology and dermatology).

Is PharmaLogic a public or private company?

PharmaLogic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PharmaLogic founded?

PharmaLogic was founded in 1984. It employs 1 to 10 people.

Where is PharmaLogic based?

PharmaLogic is headquartered in Miami, United States, in the North America region.

How does PharmaLogic make money?

One revenue line is on record: consulting Services.

Who are PharmaLogic's main competitors?

Direct peers on record are Ora, Inc., Camargo Pharmaceutical Services, ProPharma Group, Advanced Clinical and Nuventra Pharma Sciences. Broad incumbents are Worldwide Clinical Trials, Charles River Laboratories, ICON plc, Medpace and IQVIA.

Does PharmaLogic have an API?

No public API is recorded for PharmaLogic.

What industry is PharmaLogic in?

PharmaLogic's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAIAAAL, Ophthalmology Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals